Question Bank › Counterparties stepping up before the numbers do

Counterparties stepping up before the numbers do

Counterparties stepping up before the numbers do: escalating committed demand the reported results don't yet show

Calls Tested
492
Answered YES
16
Hit Rate
3.3%
rare by design

Accuray Incorporated (ARAY) — this company's answers

NO on the Q4 2016 call 2016-08-17 B
The model's full reasoning — Q4 2016 call → NO我们根据提供的财报电话会议记录来判断。管理层是否描述了付费对手方(客户等)当前正在以明显超越以往水平的方式增加承诺,并且报告的结果尚未充分反映这种增加,因为其贡献才刚刚开始且大部分还在未来。 分析: - 管理层提到了多个订单,如NHS的7台系统订单(公司历史上最大订单),以及Radixact和Onrad的新产品推出。但NHS订单是在第四季度记录的,已经计入订单和积压订单。管理层说第四季度订单创纪录,但收入增长指引为3-5%,产品收入增长6-9%。他们提到订单增长5%左右,且订单集中在后半财年。但这是否构成“付费对手方正在明显升级承诺”? - 管理层提到“多系统订单”是重要驱动,但第四季度没有签署美国的多系统订单,而是预期在2017财年分几个订单。这似乎不是升级,而是延迟。 - 关于Radixact,管理层说正在安装参考站点,预计第二季度末全面商业推出,订单影响在下半年。但这是新产品,尚未有客户承诺。 - Onrad在中国获批,但预计订单在第二季度后,且需要招标。 - 管理层没有明确说现有客户正在以更大规模或更广泛范围增加承诺。NHS订单是历史最大,但那是单一事件,且已计入订单。管理层说“我们相信2017财年将是增长年,但增长主要在下半年”,这更多是预期,而非已发生的升级。 - 管理层提到“我们继续看到TomoTherapy系统销售显著增加,第四季度订单同比增长30%”,但这是强劲需求,不一定是对手方升级。 - 关键点:管理层是否说“报告结果尚未反映已承诺的业务”?他们提到收入指引较低,因为日本延迟等,但那是延迟,不是升级。他们提到“我们预计2017财年订单增长5%”,但这是指引,不是已发生。 - 没有明确描述付费对手方已经以超越以往的水平承诺,且结果尚未反映。NHS订单是已发生的,但已计入订单,且收入将在未来转化,但管理层没有说“结果尚未反映”这个订单,而是说订单增长强劲。 - 管理层说“我们相信2017财年将是增长年,但增长主要在下半年”,这更多是预期,而非已发生的升级。 因此,答案应为NO。

← Back to the full ARAY analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that the counterparties who pay the company — customers, clients, partners, distributors, payers, or program sponsors — are CURRENTLY STEPPING UP their commitment to the company in a way that goes clearly beyond their prior level of business, AND does management convey that the reported results do not yet meaningfully reflect that step-up, because its contribution is only beginning and mostly still ahead? Answer YES when management's own words convey BOTH halves as one coherent, present-tense story, in whatever form fits the business: (1) A REAL ESCALATION BY PAYING COUNTERPARTIES, ALREADY HAPPENING OR ALREADY COMMITTED. Management describes counterparties moving to a distinctly higher level of engagement than they had before — not merely strong demand in the usual pattern. This may take whatever form fits the industry, for example: customers who started small now committing to substantially larger volumes, broader deployments, more sites, or wider scope; a counterparty moving a relationship from an initial phase into a much bigger committed phase; orders, bookings, or committed work arriving at a scale or pace beyond what the company had been receiving; buyers committing earlier, longer, or bigger than this business has been used to; or new business already won whose delivery ramps ahead. What matters is that the escalation is described as actually occurring or actually committed now — real orders, signed expansions, deliveries beginning, ramps underway — grounded in the behavior of identifiable paying counterparties, not in pipeline, interest, market size, or management's own hopes. (2) THE NUMBERS LAG THE ESCALATION, AND MANAGEMENT SAYS SO. Management conveys, directly or plainly in substance, that the results just reported still mostly reflect the business before this step-up — for example, the larger commitments have only begun converting into revenue, the ramp is early with most delivery ahead, or the company is now preparing, hiring, or building to serve committed business that has not yet flowed through the reported period — so today's numbers understate the business the counterparties have already committed to. Answer NO if the call describes only strong demand, growth, or a good quarter in the company's ordinary rhythm, without counterparties visibly moving to a higher level of commitment than before. NO if the step-up is only hoped for, in negotiation, in pipeline, or dependent on decisions, approvals, or financing not yet obtained. NO if the escalation is a single routine order or renewal of normal size for this business. NO if the increased activity is attributed mainly to a temporary spike, catch-up, pull-forward, or one-time event that management expects to fade. NO if the escalated business is already fully reflected in the reported results with nothing meaningful still to convert. NO if management is chiefly explaining delays, cancellations, or problems with a previously described ramp. NO if the idea appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
GVP GSE Systems, Inc. Q1 2023 2023-05-15 D
OEC Orion Engineered Carbons S.A. Q4 2022 2023-02-17 B+
EVGO EVgo, Inc. Q2 2022 2022-08-09 C+
SYM Symbotic Inc. Q3 2022 2022-08-01 B+
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
OOMA Ooma, Inc. Q3 2022 2021-12-02 B+
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
KOP Koppers Holdings Inc. Q2 2018 2018-08-12 C+
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
ILMN Illumina, Inc. Q1 2018 2018-04-24 A
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C
GOGO Gogo Inc. Q1 2016 2016-05-06 C+

How the model reasoned

KOP · Q2 2018 → YESThe question is: Does management describe that counterparties (customers etc.) are CURRENTLY STEPPING UP their commitment beyond prior levels, AND that reported results do not yet meaningfully reflect...**NO** The transcript does not describe any counterparties (customers, clients, partners, etc.) currently stepping up their commitment to a distinctly higher level of engagement beyond prior patterns in a way that is already occurring or committed now, with the reported results lagging because most of the benefit is still ahead. The closest item is the major box store converting its ground-contact treated wood program to Koppers’ patented MicroPro technology, planned for late fall with “little effect on the balance of 2018” and a “nice boost heading into 2019.
SCPH · Q3 2023 → YESThe question is: Does management describe that counterparties who pay the company are CURRENTLY STEPPING UP their commitment beyond prior levels, AND that the reported results do not yet meaningfully ...YES The transcript shows management describing a clear escalation in payer commitments: a new unrestricted-access agreement with the largest closed IDN (over 8 million lives, fixed copay) and preferred formulary status with a major government retiree payer (adding 1.1 million lives). They explicitly note that direct IDN purchases were not meaningful in Q3 but will be “a meaningful part of our business” moving forward, especially in 2024, and that the new payer decisions “could positively impact FUROSCIX co-pays as early as the fourth quarter.
GFS · Q3 2021 → YESThe question is: Does management describe that counterparties (customers) are CURRENTLY STEPPING UP their commitment beyond prior levels, AND that the reported results do not yet meaningfully reflect ...**YES** Management describes counterparties (customers) stepping up their commitment through new and expanded long-term agreements (LTAs) and prepayments/access fees, which have grown since the roadshow (from ~$2.5B to north of $3B, with additional $500M+ added post-roadshow) and now exceed $20B in forward revenues. This is framed as real escalation in committed business, with customers signing more agreements and prepaying for future capacity. The reported Q3 results ($1.7B revenue, $0.07 adjusted EPS) and Q4 guidance ($1.

More from the question bank

Escape velocity out of a small baseCash cost of the waitPromise already turning into factMomentum handoff to a young engineCustomers coming back on their ownScheduled future in administrationAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.